Systems and methods related to ST segment monitoring by an implantable medical device
    31.
    发明授权
    Systems and methods related to ST segment monitoring by an implantable medical device 有权
    通过植入式医疗装置与ST段监测相关的系统和方法

    公开(公告)号:US08467862B2

    公开(公告)日:2013-06-18

    申请号:US13049805

    申请日:2011-03-16

    CPC classification number: A61B5/0452 A61B5/7264

    Abstract: Cardiac activity is sensed over a plurality of heart beats defining a beat set. For each beat in the set, it is determined whether the beat is a non-classified beat (e.g., paced beat, a beat outside of a specified heart rate range or a PVC), or a classified beat. For each classified beat, it is determined whether the beat is a non-detect beat, a minor beat or a major beat. Counts of classified beats, non-classified beats, major beats, minor beats, and non-detect beats are maintained. The beat set is declared to be one of a non-classified set, a major set, a minor set or a non-detect set based on the relative counts of classified beats, non-classified beats, major beats, minor beats, and non-detect beats. Over a period of time, counts of beat-set types are maintained and entry into and exit from ST episodes are determined based on these beat-set counts.

    Abstract translation: 在定义拍子组的多个心跳上感测到心脏活动。 对于集合中的每个节拍,确定节拍是否是非分类节拍(例如,节奏拍子,指定心率范围或PVC之外的节拍)或分类节拍。 对于每个分类的节拍,确定节拍是否是非检测节拍,小节奏或主要节拍。 维持分类节拍,非分类节拍,主要节拍,次要节拍和非检测节拍的数量。 基于分类节拍,非分类节拍,主要节拍,次要节拍和非节奏组合的相对计数,节拍组被宣布为非分类集,主要集,未成年集或未检测集之一。 检测节拍 在一段时间内,基于这些节拍设置计算确定节拍类型的计数,并且进入和退出ST剧集。

    Polarization-controlled encoding method, encoder, and quantum key distribution system
    32.
    发明授权
    Polarization-controlled encoding method, encoder, and quantum key distribution system 有权
    极化控制编码方法,编码器和量子密钥分配系统

    公开(公告)号:US08331797B2

    公开(公告)日:2012-12-11

    申请号:US10588042

    申请日:2004-08-19

    CPC classification number: H04L9/0858

    Abstract: The invention relates to a polarization-controlled encoding method, encoder and quantum key distribution system, which is characterized in that polarization maintaining light path or 90 degree rotation Faraday mirror are used inside the encoder to keep the polarization of the output pulses same, and that in the quantum key distribution system employing the polarization-controlled encoder the pulse emitted from transmitter is unidirectional-transmitted to receiver and then quantum key distribution is implemented using interference in the pulses according to the quantum key distribution protocol. The quantum key distribution system using the polarization-controlled encoder of the invention has the ability of avoiding the wiretapping to transmitter, receiver and quantum channel. Detection units each of which separates reversed photon from other photons are added at the out port of the transmitter and the in port of receiver, respectively, so that Trojan horse is prevented from entering and photons with phase modulated information are prevented from leaving the safe area in receiver. Unconditionally safe key distribution can be accomplished by using the quantum key distribution system of the invention.

    Abstract translation: 本发明涉及一种偏振控制编码方法,编码器和量子密钥分发系统,其特征在于在编码器内部使用偏振保持光路或90度旋转法拉第镜,以保持输出脉冲的极化相同, 在使用偏振控制编码器的量子密钥分配系统中,从发射机发射的脉冲是单向传输到接收机,然后根据量子密钥分配协议在脉冲中使用干扰来实现量子密钥分配。 使用本发明的偏振控制编码器的量子密钥分发系统具有避免对发射机,接收机和量子信道的窃听的能力。 检测单元分别将反向光子与其他光子分离,分别在发射机的出口和接收机的入口端口分别加入,防止特洛伊木马进入,防止具有相位调制信息的光子离开安全区域 在接收器。 通过使用本发明的量子密钥分发系统可以实现无条件的安全密钥分发。

    HPV antigen fusion protein vaccine compositions and uses thereof
    33.
    发明授权
    HPV antigen fusion protein vaccine compositions and uses thereof 有权
    HPV抗原融合蛋白疫苗组合物及其用途

    公开(公告)号:US08187606B2

    公开(公告)日:2012-05-29

    申请号:US12446382

    申请日:2007-10-19

    Abstract: The present invention provides a fusion protein comprising an immunostimulatory polypeptide and a mutant E7 protein of a human papilloma virus. The present invention also provides a gene encoding the fusion protein, expression vectors containing the gene, a pharmaceutical composition comprising the fusion protein, a method for treating or preventing a human papilloma virus related disease by using the fusion protein and uses of the fusion protein in the preparation of a medicament for the treatment or prevention of the human papilloma virus related disease.

    Abstract translation: 本发明提供了包含免疫刺激多肽和人乳头瘤病毒的突变E7蛋白的融合蛋白。 本发明还提供了编码融合蛋白的基因,含有该基因的表达载体,包含该融合蛋白的药物组合物,通过使用融合蛋白治疗或预防人乳头状瘤病毒相关疾病的方法以及融合蛋白的用途 制备用于治疗或预防人乳头状瘤病毒相关疾病的药物。

    Apparatus and method for transporting radiopharmaceuticals
    34.
    发明申请
    Apparatus and method for transporting radiopharmaceuticals 审中-公开
    用于运输放射性药物的装置和方法

    公开(公告)号:US20090294700A1

    公开(公告)日:2009-12-03

    申请号:US11891310

    申请日:2007-08-08

    CPC classification number: G21F5/018 A61M5/1785 Y10T29/49826 Y10T29/49904

    Abstract: A method and apparatus for transporting radiopharmaceuticals. Typically, the apparatus is a two-part assembly, each part having an exterior shell, a radiation shield and a non-porous lining. Additionally, the assembled apparatus has a sealed internal chamber suitable for carrying a syringe or a sharps container containing a syringe. The internal chamber of the radiopharmaceutical pig is lined with a non-porous lining, typically a durable plastic, that prevents contamination of the radiopharmaceutical doses, the radiation shield, or the environment. Additionally, the non-porous lining can be quickly and easily cleaned and sterilized, avoiding the often difficult, to impossible, task of cleaning and sterilizing the radiation shield of the radiopharmaceutical pig. The non-porous lining is surrounded by a radiation shield that is typically comprised of elemental lead. The radiation shield prevents radiation from the radiopharmaceutical from contaminating the user or environment. The radiation shield is surrounded by an exterior shell that absorbs impact and prevents the radiopharmaceutical pig from breaking. Additionally, the exterior shell prevents environmental exposure to the potentially hazardous material of the radiation shield. Generally, a method of transporting a radiopharmaceutical by filling the container with a radiopharmaceutical, inserting the container into the internal chamber of the radiopharmaceutical pig having a non-porous lining, and assembling the radiopharmaceutical pig so the that the container is in the internal chamber and is encapsulated by the radiation shield, is also provided.

    Abstract translation: 用于运输放射性药物的方法和装置。 通常,该设备是两部分组件,每个部件具有外壳,辐射屏蔽和无孔衬里。 此外,组装的装置具有适于携带注射器或含有注射器的锐器容器的密封内部腔室。 放射性药物猪的内部室内衬有无孔衬里,通常是耐用的塑料,其防止放射性药物剂量,辐射屏蔽或环境的污染。 此外,无孔衬里可以快速且容易地清洁和消毒,避免了对放射性药物猪的辐射屏蔽进行清洁和消毒的常常困难的,不可能的任务。 无孔衬里由通常由元素铅构成的辐射屏蔽围绕。 辐射屏蔽防止放射性药物的辐射污染用户或环境。 辐射屏蔽被外壳包围,吸收冲击并防止放射性药物猪破裂。 此外,外壳防止环境暴露于辐射屏蔽层的潜在危险物质。 通常,通过用放射性药剂填充容器来输送放射性药物的方法,将容器插入具有无孔衬里的放射性药物猪的内部室中,并且组装放射性药物猪使得容器处于内部室中, 被辐射屏蔽封装,也被提供。

    Polarization-Controlled Encoding Method, Encoder, And Quantum Key Distribution System
    35.
    发明申请
    Polarization-Controlled Encoding Method, Encoder, And Quantum Key Distribution System 有权
    极化控制编码方法,编码器和量子密钥分配系统

    公开(公告)号:US20080037998A1

    公开(公告)日:2008-02-14

    申请号:US10588042

    申请日:2004-08-19

    CPC classification number: H04L9/0858

    Abstract: The invention relates to a polarization-controlled encoding method, encoder and quantum key distribution system, which is characterized in that polarization maintaining light path or 90 degree rotation Faraday mirror are used inside the encoder to keep the polarization of the output pulses same, and that in the quantum key distribution system employing the polarization-controlled encoder the pulse emitted from transmitter is unidirectional-transmitted to receiver and then quantum key distribution is implemented using interference in the pulses according to the quantum key distribution protocol. The quantum key distribution system using the polarization-controlled encoder of the invention has the ability of avoiding the wiretapping to transmitter, receiver and quantum channel. Detection units each of which separates reversed photon from other photons are added at the out port of the transmitter and the in port of receiver, respectively, so that Trojan horse is prevented from entering and photons with phase modulated information are prevented from leaving the safe area in receiver. Unconditionally safe key distribution can be accomplished by using the quantum key distribution system of the invention.

    Abstract translation: 本发明涉及一种偏振控制编码方法,编码器和量子密钥分发系统,其特征在于在编码器内部使用偏振保持光路或90度旋转法拉第镜,以保持输出脉冲的极化相同, 在使用偏振控制编码器的量子密钥分配系统中,从发射机发射的脉冲是单向传输到接收机,然后根据量子密钥分配协议在脉冲中使用干扰来实现量子密钥分配。 使用本发明的偏振控制编码器的量子密钥分发系统具有避免对发射机,接收机和量子信道的窃听的能力。 检测单元分别将反向光子与其他光子分离,分别在发射机的出口和接收机的入口端口分别加入,防止特洛伊木马进入,防止具有相位调制信息的光子离开安全区域 在接收器。 通过使用本发明的量子密钥分发系统可以实现无条件的安全密钥分发。

    Exchange structure and a method of connection configuration between the optical networks
    36.
    发明申请
    Exchange structure and a method of connection configuration between the optical networks 审中-公开
    交换结构和光网络之间的连接配置方法

    公开(公告)号:US20070014573A1

    公开(公告)日:2007-01-18

    申请号:US10570181

    申请日:2003-09-01

    CPC classification number: H04B10/271 H04B10/27 H04B10/275

    Abstract: The invention discloses an interconnection structure and a method for configuring path between the optical networks. The optical network includes a first network and a second network, the first network and the second network each has a number of nodes, a first node of the first network connects with a third node of the second network, a second node of the first network connects with a fourth node of the second network. The method comprises the steps of: setting-up a first path between one of the first node and the second node and another node of the first network; and at least by one link of the link between the first node and the third node and that between the second node and the fourth node, and by the first path, said another node of the first network communicates for path with another node of the second network. By the dual-node interconnection structure and the path configuration shceme of this invention between a ring network and a mesh network, and between mesh networks, the respective advantages of the ring network and the mesh metwork in regard to protection and restoration can be combined effectively, and the existing internetworking schemes between the rings are also compatible.

    Abstract translation: 本发明公开了一种用于配置光网络之间的路由的互连结构和方法。 光网络包括第一网络和第二网络,第一网络和第二网络各自具有多个节点,第一网络的第一节点与第二网络的第三节点连接,第一网络的第二节点 与第二网络的第四节点连接。 该方法包括以下步骤:在第一节点和第二节点之一以及第一网络的另一个节点之间建立第一路径; 以及所述第一节点和所述第三节点之间的链路以及所述第二节点和所述第四节点之间的链路的至少一个链路,并且通过所述第一路径,所述第一网络的所述另一个节点与所述第二节点的另一个节点进行通信 网络。 通过环形网络和网状网络之间以及网状网络之间的本发明的双节点互连结构和路径配置,可以有效地组合环网和网状网络在保护和恢复方面的各自优点 ,并且环之间的现有互联方案也是兼容的。

    SYSTEM AND METHOD FOR ANALYZING POWER CONSUMPTION OF ELECTRONIC DESIGN UNDERGOING EMULATION OR HARDWARE BASED SIMULATION ACCELERATION
    37.
    发明申请
    SYSTEM AND METHOD FOR ANALYZING POWER CONSUMPTION OF ELECTRONIC DESIGN UNDERGOING EMULATION OR HARDWARE BASED SIMULATION ACCELERATION 有权
    用于分析基于仿真或硬件仿真加速的电子设计功耗的系统和方法

    公开(公告)号:US20060277509A1

    公开(公告)日:2006-12-07

    申请号:US11422314

    申请日:2006-06-05

    CPC classification number: G06F17/5022 G06F17/5027 G06F2217/78

    Abstract: The invention described here is the methods of using a hardware-based functional verification system to mimic a design under test (DUT), under intended application environment and software, to record or derive the transition activities of all circuits of the DUT, then calculate the total or partial power consumption during the period of interest. The period of interest is defined by the user in terms of “events” which are the arbitrary states of the DUT. Furthermore, the user can specify the number of sub-divisions required between events thus vary the apparent resolution of the power consumption profile.

    Abstract translation: 这里描述的发明是使用基于硬件的功能验证系统在预期的应用环境和软件下模拟被测设计(DUT)来记录或导出DUT的所有电路的转换活动的方法,然后计算 在兴趣期间的全部或部分功耗。 感兴趣的时期由用户根据DUT的任意状态的“事件”定义。 此外,用户可以指定事件之间所需的子分割的数量,从而改变功耗简档的视在分辨率。

Patent Agency Ranking